Pharma

The Readout Elaine Chen

STAT Plus: Lilly takes more actions against unapproved versions of Mounjaro

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Merck pneumococcal shot, Kansas suing Pfizer, and more

The Readout Adam Feuerstein

STAT Plus: A biotech’s binary bet ends badly

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about an ‘unaffordable’ Novartis drug, a proposed patent rule, and more

The Readout Meghana Keshavan

STAT Plus: FDA offers new guidelines for Covid-19 vaccine

Pharmalot Ed Silverman

STAT Plus: Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly?

Pharmalot Ed Silverman

STAT Plus: Colorado board decides a pricey Novartis medicine is unaffordable

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about abortion pill access, employer coverage of GLP-1 drugs and more

The Readout Elaine Chen

STAT Plus: J.P. Morgan has officially jumped into early stage biotech investing

Biotech Sarah Owermohle, Allison DeAngelis, and Adam Feuerstein

STAT Plus: Biopharma execs cheer Supreme Court for upholding FDA authority in abortion pill case

The Readout Meghana Keshavan

With Avidity and Pfizer, gene therapy enters a phase

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Pfizer drug for Duchenne, bird flu vaccines for cows, and more

Exclusive Rachel Cohrs Zhang

Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea

Pharma Andrew Joseph

STAT Plus: Europe is set to shake up the way it assesses new medicines. Gene therapy makers are worried

Pharma Jason Mast

STAT Plus: Pfizer’s gene therapy for Duchenne muscular dystrophy fails in Phase 3 trial

The Readout Elaine Chen

STAT Plus: What do Parkinson’s and obesity have in common?

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Sanders dogging Novo Nordisk, Teva patents, and more

Video Anna Yeo

STAT Plus: Watch: How pharmacy benefit managers influence drug pricing

Video Anna Yeo

STAT Plus: Watch: The role of PBMs, patents, and public health in drug pricing

Politics Rachel Cohrs Zhang and Elaine Chen

STAT Plus: Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices

The Readout Elaine Chen

Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know

Pharmalot Andrew Joseph

STAT Plus: Pharmalittle: We’re reading about Lilly’s Alzheimer’s drug, an EU contract for bird flu vaccine, and more

The Readout Meghana Keshavan

The biotech news you missed from the weekend

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Moderna Covid-flu vaccine, a paused Pfizer study, and more

Health Helen Branswell

STAT Plus: FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults

The Readout Meghana Keshavan

STAT Plus: Vanda Pharmaceuticals has another suitor

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Jason Mast

STAT Plus: Pharmalittle: We’re reading about Lilly’s Alzheimer’s drug, the GSK-Elsie deal, and more